Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection.

Author Department

Medicine

Document Type

Article, Peer-reviewed

Publication Date

2-1-2007

Abstract

BACKGROUND: We evaluated the efficacy and safety of oral posaconazole for human immunodeficiency virus (HIV)-infected subjects with oropharyngeal candidiasis (OPC) and/or esophageal candidiasis (EC) who were clinically refractory to treatment with oral fl

Publication ISSN

0884-8734

Share

COinS